Global Artificial Intelligence in Diagnostics Market Size, Trends & Growth Opportunity, By Component (Software, Hardware, and Services), By Diagnosis Type (Cardiology, Oncology, Pathology, Radiology, Neurology, and Others),By Region and Forecast till 2027.
Global Artificial Intelligence in Diagnostics Market
Global Artificial Intelligence in Diagnostics Market was valued at USD  839.8 million in 2022 and is slated to reach at USD  3290 million by 2027 at a CAGR of 22.57% from 2022-2027.
AI (Artificial Intelligence) refers to creation of unique systems with the help of software which can perform certain tasks without human intervention and instructions. AI comprises integration of various technologies like machine learning, reasoning, perception, natural language processing. AI is primary used in healthcare sector for diagnosis and treatment. 
Market Drivers
Increase in applications of AI (artificial intelligence) in healthcare industry is the key driving factor which is expected to boost the global artificial intelligence in diagnostics market growth. Furthermore, rise in demand for reducing diagnostic costs, reducing machine downtime and improving patient care will accelerate the usage of artificial intelligence in diagnostics and which is expected to propel the market growth during this forecast period. Also, increase in collaboration and partnership activities among various AI solution providers and health facilities will positively contribute the market growth. Moreover, continuous advancements in artificial intelligence and deep learning are expected to prove more efficient in identifying disease diagnosis over the upcoming years.
Know more about this report: request for sample pages
Market Restraints
However, lack of skilled AI workforce and ambiguous regulatory guidelines for diagnostic software is the major challenging factor which is expected to hinder the global artificial intelligence in diagnostics market growth during this analysis period.
Impact of COVID-19
The COVID-19 pandemic epidemic had a negative impact on the worldwide healthcare industry. The COVID-19 infection rate increased dramatically, placing a tremendous strain on the global health system. Patients with COVID-19 typically experience lung problems. Therefore, to determine the severity of the disease in COVID-19 instances, cardiothoracic imaging is a standard diagnostic procedure. In 2020, the number of studies utilising AI to diagnose COVID-19 quickly expanded. Numerous studies concentrated on utilising AI to diagnose COVID-19 from chest CT images. Numerous investigations revealed that when it came to diagnosing COVID-19, AI models were just as reliable as skilled radiologists.

Recent developments 
August 2020 saw the acquisition of 3Derm Systems by Digital Diagnostics. The company's goal after this acquisition was to use 3Derm's autonomous AI to improve healthcare quality while reducing suffering and expenses.
Silexica, a developer of C/C++ programming and analysis tools, was bought by Xilinx in June 2021. With the help of Silexica's software programmability, the corporation hoped to hasten the transition from software to application-optimized hardware systems. Additionally, this acquisition would enhance the current Vitis solution and have the ability to appeal to a wider range of developers.
Market segmentation
Global Artificial Intelligence in Diagnostics Market is segmented into component such as Software, Hardware, and Services. Further, market is segmented into diagnosis type such as Cardiology, Oncology, Pathology, Radiology, Neurology, and Others.
Regional Analysis
Also, Global Artificial Intelligence in Diagnostics Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific,  
Market key Players
Various key players are discussed in this report such as GE Healthcare,Siemens Healthcare GmbH, IDx Technologies Inc., Vuno Inc., Imagen Technologies, AliveCor, Aidoc, Neural Analytics, Riverain Technologies, and Zebra Medical Vision
Market Taxonomy
By Component
• Software
• Hardware
• Services
By Diagnosis Type
• Cardiology
• Oncology
• Pathology
• Radiology
• Neurology
• Others
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Key Questions Addressed by the Report
• What are the Key Opportunities in Global Artificial Intelligence in Diagnostics Market?
• What will be the growth rate from 2022 to 2027?
• Which segment/region will have highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?
• What are the strategies adopted by key players?

Artificial Intelligence in Diagnostics Market ,Artificial Intelligence in Diagnostics  Industry,Artificial Intelligence in Diagnostics  Market Size,Artificial Intelligence in Diagnostics   Market Share,Artificial Intelligence in Diagnostics  Market Trend,Artificial Intelligence in Diagnostics   Market Growth

Global Artificial Intelligence in Diagnostics Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Artificial Intelligence in Diagnostics Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5. Global Artificial Intelligence in Diagnostics Market, By Component
5.1 Y-o-Y Growth Comparison, By Component 
5.2 Global Artificial Intelligence in Diagnostics Market Share Analysis, By Component 
5.3 Global Artificial Intelligence in Diagnostics Market Size and Forecast, By Component
5.3.1 Software
5.3.2 Hardware
5.3.3. Services
6 .Global Artificial Intelligence in Diagnostics Market, By Diagnosis Type
6.1 Y-o-Y Growth Comparison, By Diagnosis Type
6.2 Global Artificial Intelligence in Diagnostics Market Share Analysis, By Diagnosis Type
6.3 Global Artificial Intelligence in Diagnostics Market Size and Forecast, By Diagnosis Type
6.3.1 Cardiology
6.3.2 Oncology
6.3.3 Pathology
6.3.4. Radiology
6.3.5. Neurology
6.3.6 .Others
7Global Artificial Intelligence in Diagnostics Market, By Region
7.1 Global Artificial Intelligence in Diagnostics Market Share Analysis, By Region
7.2 Global Artificial Intelligence in Diagnostics Market Share Analysis, By Region
7.3 Global Artificial Intelligence in Diagnostics Market Size and Forecast, By Region
8North America Artificial Intelligence in Diagnostics Market Analysis and Forecast (2022 – 2027)
1 Introduction
8.2 North America Artificial Intelligence in Diagnostics Market Share Analysis, By Component
8.3 North America Artificial Intelligence in Diagnostics Market Size and Forecast, By Diagnosis Type
8.4 North America Artificial Intelligence in Diagnostics Market Size and Forecast, By Country
8.4.1 U.S
8.4.2 Canada
8.4.3 Mexico
9Europe Artificial Intelligence in Diagnostics Market Analysis and Forecast (2022 – 2027)
9.1 Introduction
9.2 Europe Artificial Intelligence in Diagnostics Market Share Analysis, By Component 
9.3 Europe Artificial Intelligence in Diagnostics Market Size and Forecast, By Diagnosis Type 
9.4 Europe Artificial Intelligence in Diagnostics Market Size and Forecast, By Country
9.4.1 Germany
9.4.2 France
9.4.3 UK
9.4.4. Rest of Europe
10Asia Pacific Artificial Intelligence in Diagnostics Market Analysis and Forecast (2022 – 2027)
10.1 Introduction
10.2 Asia Pacific Artificial Intelligence in Diagnostics Market Share Analysis, By Component 
10.3 Asia Pacific Artificial Intelligence in Diagnostics Market Size and Forecast, By Diagnosis Type 
10.4 Asia Pacific Artificial Intelligence in Diagnostics Market Size and Forecast, By Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4. Rest of Asia Pacific
11Latin America Artificial Intelligence in Diagnostics Market Analysis and Forecast (2022 – 2027)
11.1 Introduction
11.2 Latin America Artificial Intelligence in Diagnostics Market Share Analysis, By Component 
11.3 Latin America Artificial Intelligence in Diagnostics Market Size and Forecast, By Diagnosis Type 
11.4 Latin America Artificial Intelligence in Diagnostics Market Size and Forecast, By Country
12Middle East Artificial Intelligence in Diagnostics Market Analysis and Forecast (2022 – 2027)
12.1 Introduction
12.2 Middle East Artificial Intelligence in Diagnostics Market Share Analysis, By Component 
12.3 Middle East Artificial Intelligence in Diagnostics Market Size and Forecast, By Diagnosis Type 
12.4 Middle East Artificial Intelligence in Diagnostics Market Size and Forecast, By Country
13Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14Company Profiles
15.1 GE Healthcare 
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Siemens Healthcare GmbH
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 , IDx Technologies Inc
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Vuno Inc
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Imagen Technologies
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 AliveCor
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Aidoc
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Neural Analytics
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Riverain Technologies
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Zebra Medical Vision
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies

"